Table of Content

1 Study Coverage
1.1 Meningococcal Infections Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Meningococcal Infections Vaccine Market by Region
1.4.1 Global Meningococcal Infections Vaccine Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Meningococcal Infections Vaccine Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Meningococcal Infections Vaccine Revenue by Players
2.1.1 Global Meningococcal Infections Vaccine Revenue by Players (2019-2024)
2.1.2 Global Meningococcal Infections Vaccine Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Meningococcal Infections Vaccine Revenue in 2024
2.2 Global Meningococcal Infections Vaccine Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Meningococcal Infections Vaccine Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Sanofi-Pasteur
3.1.1 Sanofi-Pasteur Information
3.1.2 Sanofi-Pasteur Overview
3.1.3 Sanofi-Pasteur Meningococcal Infections Vaccine Revenue and Gross Margin (2019-2024)
3.1.4 Sanofi-Pasteur Related Developments
3.2 Beijing Tiantan Biological Products
3.2.1 Beijing Tiantan Biological Products Information
3.2.2 Beijing Tiantan Biological Products Overview
3.2.3 Beijing Tiantan Biological Products Meningococcal Infections Vaccine Revenue and Gross Margin (2019-2024)
3.2.4 Beijing Tiantan Biological Products Related Developments
3.3 Shanghai Institute of Biological Products
3.3.1 Shanghai Institute of Biological Products Information
3.3.2 Shanghai Institute of Biological Products Overview
3.3.3 Shanghai Institute of Biological Products Meningococcal Infections Vaccine Revenue and Gross Margin (2019-2024)
3.3.4 Shanghai Institute of Biological Products Related Developments
3.4 Wuhan Institute of Biological Products
3.4.1 Wuhan Institute of Biological Products Information
3.4.2 Wuhan Institute of Biological Products Overview
3.4.3 Wuhan Institute of Biological Products Meningococcal Infections Vaccine Revenue and Gross Margin (2019-2024)
3.4.4 Wuhan Institute of Biological Products Related Developments
3.5 Lanzhou Institute of Biological Products
3.5.1 Lanzhou Institute of Biological Products Information
3.5.2 Lanzhou Institute of Biological Products Overview
3.5.3 Lanzhou Institute of Biological Products Meningococcal Infections Vaccine Revenue and Gross Margin (2019-2024)
3.5.4 Lanzhou Institute of Biological Products Related Developments
3.6 Hualan Biological Engineering
3.6.1 Hualan Biological Engineering Information
3.6.2 Hualan Biological Engineering Overview
3.6.3 Hualan Biological Engineering Meningococcal Infections Vaccine Revenue and Gross Margin (2019-2024)
3.6.4 Hualan Biological Engineering Related Developments
3.7 Chongqing Zhifei Biological Products
3.7.1 Chongqing Zhifei Biological Products Information
3.7.2 Chongqing Zhifei Biological Products Overview
3.7.3 Chongqing Zhifei Biological Products Meningococcal Infections Vaccine Revenue and Gross Margin (2019-2024)
3.7.4 Chongqing Zhifei Biological Products Related Developments
3.8 Zhejiang Tianyuan Bio-Pharmaceutical
3.8.1 Zhejiang Tianyuan Bio-Pharmaceutical Information
3.8.2 Zhejiang Tianyuan Bio-Pharmaceutical Overview
3.8.3 Zhejiang Tianyuan Bio-Pharmaceutical Meningococcal Infections Vaccine Revenue and Gross Margin (2019-2024)
3.8.4 Zhejiang Tianyuan Bio-Pharmaceutical Related Developments
3.9 Walvax Biotechnology
3.9.1 Walvax Biotechnology Information
3.9.2 Walvax Biotechnology Overview
3.9.3 Walvax Biotechnology Meningococcal Infections Vaccine Revenue and Gross Margin (2019-2024)
3.9.4 Walvax Biotechnology Related Developments
4 Global Meningococcal Infections Vaccine Market Insights
4.1 Global Meningococcal Infections Vaccine Market Revenue 2019-2024
4.2 Global Meningococcal Infections Vaccine Revenue by Region
4.3 Americas
4.4 Europe
4.5 Asia-Pacific
4.6 Middle East & Africa
5 Market Size by Type
5.1 Global Meningococcal Infections Vaccine Revenue by Type
5.2 Global Meningococcal Infections Vaccine Market Size Growth by Type 2019-2024
6 Market Size by Application
6.1 Global Meningococcal Infections Vaccine Revenue by Application
6.2 Global Meningococcal Infections Vaccine Market Size Growth by Application 2019-2024
7 Americas
7.1 Americas Meningococcal Infections Vaccine Market Size by Type
7.1.1 Americas Meningococcal Infections Vaccine Revenue by Type (2019-2024)
7.1.2 Americas Meningococcal Infections Vaccine Revenue Share by Type (2019-2024)
7.2 Americas Meningococcal Infections Vaccine Market Size by Application
7.2.1 Americas Meningococcal Infections Vaccine Revenue by Application (2019-2024)
7.2.2 Americas Meningococcal Infections Vaccine Revenue Share by Application (2019-2024)
7.3 Americas Meningococcal Infections Vaccine Market Size by Country
7.3.1 Americas Meningococcal Infections Vaccine Revenue by Country (2019-2024)
7.3.2 U.S.
7.3.3 Canada
7.3.4 Mexico
7.3.5 Brazil
7.3.6 Argentina
8 Europe
8.1 Europe Meningococcal Infections Vaccine Market Size by Type
8.1.1 Europe Meningococcal Infections Vaccine Revenue by Type (2019-2024)
8.1.2 Europe Meningococcal Infections Vaccine Revenue Share by Type (2019-2024)
8.2 Europe Meningococcal Infections Vaccine Market Size by Application
8.2.1 Europe Meningococcal Infections Vaccine Revenue by Application (2019-2024)
8.2.2 Europe Meningococcal Infections Vaccine Revenue Share by Application (2019-2024)
8.3 Europe Meningococcal Infections Vaccine Market Size by Country
8.3.1 Europe Meningococcal Infections Vaccine Revenue by Country (2019-2024)
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
9 Asia Pacific
9.1 Asia Pacific Meningococcal Infections Vaccine Market Size by Type
9.1.1 Asia Pacific Meningococcal Infections Vaccine Revenue by Type (2019-2024)
9.1.2 Asia Pacific Meningococcal Infections Vaccine Revenue Share by Type (2019-2024)
9.2 Asia Pacific Meningococcal Infections Vaccine Market Size by Application
9.2.1 Asia Pacific Meningococcal Infections Vaccine Revenue by Application (2019-2024)
9.2.2 Asia Pacific Meningococcal Infections Vaccine Revenue Share by Application (2019-2024)
9.3 Asia Pacific Meningococcal Infections Vaccine Market Size by Region
9.3.1 Asia Pacific Meningococcal Infections Vaccine Revenue by Region (2019-2024)
9.3.2 China
9.3.3 Japan
9.3.4 South Korea
9.3.5 India
9.3.6 Southeast Asia
9.3.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Meningococcal Infections Vaccine Market Size by Type
10.1.1 Middle East and Africa Meningococcal Infections Vaccine Revenue by Type (2019-2024)
10.1.2 Middle East and Africa Meningococcal Infections Vaccine Revenue Share by Type (2019-2024)
10.2 Middle East and Africa Meningococcal Infections Vaccine Market Size by Application
10.2.1 Middle East and Africa Meningococcal Infections Vaccine Revenue by Application (2019-2024)
10.2.2 Middle East and Africa Meningococcal Infections Vaccine Revenue Share by Application (2019-2024)
10.3 Middle East and Africa Meningococcal Infections Vaccine Market Size by Country
10.3.1 Middle East and Africa Meningococcal Infections Vaccine Revenue by Country (2019-2024)
10.3.2 Turkey
10.3.3 Saudi Arabia
10.3.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Meningococcal Infections Vaccine Industry Trends
11.2 Meningococcal Infections Vaccine Market Drivers
11.3 Meningococcal Infections Vaccine Market Challenges
11.4 Meningococcal Infections Vaccine Market Restraints
12 Meningococcal Infections Vaccine Forecasted Market Size by Type
12.1 Global Meningococcal Infections Vaccine Forecasted Revenue by Type
12.2 Global Meningococcal Infections Vaccine Forecasted Market Size Growth by Type 2024-2030
13 Meningococcal Infections Vaccine Forecasted Market Size by Application
13.1 Global Meningococcal Infections Vaccine Forecasted Revenue by Application
13.2 Global Meningococcal Infections Vaccine Forecasted Market Size Growth by Application 2024-2030
14 Global Meningococcal Infections Vaccine Market Forecasts
14.1 Global Meningococcal Infections Vaccine Market Revenue Forecasts 2024-2030
14.2 Global Meningococcal Infections Vaccine Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Meningococcal Infections Vaccine Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Meningococcal Infections Vaccine Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Meningococcal Infections Vaccine Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Meningococcal Infections Vaccine Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer